The trajectory of companies tied to Sildenafil's history presents a challenging investment scenario . While the initial success generated substantial returns , generic copies have significantly eroded market https://socialbuzzfeed.com/story7188763/copyright-s-flagship-product-and-big-pharma-a-risky-opportunity